236 related articles for article (PubMed ID: 26198272)
1. Oncologists' End of Life Treatment Decisions.
Bluhm M; Connell CM; Janz N; Bickel K; DeVries R; Silveira M
J Appl Gerontol; 2017 Apr; 36(4):416-440. PubMed ID: 26198272
[TBL] [Abstract][Full Text] [Related]
2. Paradox of Prescribing Late Chemotherapy: Oncologists Explain.
Bluhm M; Connell CM; De Vries RG; Janz NK; Bickel KE; Silveira MJ
J Oncol Pract; 2016 Dec; 12(12):e1006-e1015. PubMed ID: 27650843
[TBL] [Abstract][Full Text] [Related]
3. Oncologists' Views on Using Value to Guide Cancer Treatment Decisions.
Gidwani-Marszowski R; Nevedal AL; Blayney DW; Patel M; Kelly PA; Timko C; Ramchandran K; Murrell SS; Asch SM
Value Health; 2018 Aug; 21(8):931-937. PubMed ID: 30098670
[TBL] [Abstract][Full Text] [Related]
4. Oncologists' views on the importance of general practitioners for cancer patients: a qualitative interview study from Germany.
Engler J; Kone I; Holmberg C; Baumann W; Siebenhofer A; Güthlin C
Fam Pract; 2017 Nov; 34(6):730-734. PubMed ID: 28486693
[TBL] [Abstract][Full Text] [Related]
5. The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study.
Berry SR; Hubay S; Soibelman H; Martin DK
BMC Health Serv Res; 2007 Nov; 7():193. PubMed ID: 18042302
[TBL] [Abstract][Full Text] [Related]
6. The Appropriate Provision of Primary versus Specialist Palliative Care to Cancer Patients: Oncologists' Perspectives.
Gidwani R; Nevedal A; Patel M; Blayney DW; Timko C; Ramchandran K; Kelly PA; Asch SM
J Palliat Med; 2017 Apr; 20(4):395-403. PubMed ID: 27997278
[TBL] [Abstract][Full Text] [Related]
7. How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.
Moth EB; Kiely BE; Naganathan V; Martin A; Blinman P
Support Care Cancer; 2018 Feb; 26(2):451-460. PubMed ID: 28776149
[TBL] [Abstract][Full Text] [Related]
8. Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.
Mohile SG; Magnuson A; Pandya C; Velarde C; Duberstein P; Hurria A; Loh KP; Wells M; Plumb S; Gilmore N; Flannery M; Wittink M; Epstein R; Heckler CE; Janelsins M; Mustian K; Hopkins JO; Liu J; Peri S; Dale W
J Natl Compr Canc Netw; 2018 Mar; 16(3):301-309. PubMed ID: 29523669
[No Abstract] [Full Text] [Related]
9. Patients' and oncologists' views on how oncologists may best address patients' emotions during consultations: An interview study.
Visser LNC; Schepers S; Tollenaar MS; de Haes HCJM; Smets EMA
Patient Educ Couns; 2018 Jul; 101(7):1223-1231. PubMed ID: 29534845
[TBL] [Abstract][Full Text] [Related]
10. Facilitators and Barriers to Oncologists' Conduct of Goals of Care Conversations.
Schulman-Green D; Lin JJ; Smith CB; Feder S; Bickell NA
J Palliat Care; 2018 Jul; 33(3):143-148. PubMed ID: 29790421
[TBL] [Abstract][Full Text] [Related]
11. Oncologists' and Patients' Perceptions of Initial, Intermediate, and Final Goals of Care Conversations.
Schulman-Green D; Smith CB; Lin JJ; Feder S; Bickell NA
J Pain Symptom Manage; 2018 Mar; 55(3):890-896. PubMed ID: 29030209
[TBL] [Abstract][Full Text] [Related]
12. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
[TBL] [Abstract][Full Text] [Related]
13. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
Schrag D; Hanger M
J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
[TBL] [Abstract][Full Text] [Related]
14. Shared decision making about palliative chemotherapy: A qualitative observation of talk about patients' preferences.
Henselmans I; Van Laarhoven HW; Van der Vloodt J; De Haes HC; Smets EM
Palliat Med; 2017 Jul; 31(7):625-633. PubMed ID: 28618897
[TBL] [Abstract][Full Text] [Related]
15. Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives.
O'Neill SC; Taylor KL; Clapp J; Jayasekera J; Isaacs C; Mary Atieh Graham D; Goldberg SL; Mandelblatt J
J Health Commun; 2018; 23(7):679-686. PubMed ID: 30130477
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study.
Puts MT; Sattar S; McWatters K; Lee K; Kulik M; MacDonald ME; Jang R; Amir E; Krzyzanowska MK; Leighl N; Fitch M; Joshua AM; Warde P; Tourangeau AE; Alibhai SM
Support Care Cancer; 2017 Mar; 25(3):879-886. PubMed ID: 27830393
[TBL] [Abstract][Full Text] [Related]
17. Chinese oncologists' knowledge, attitudes and practice towards palliative care and end of life issues.
Gu X; Cheng W
BMC Med Educ; 2016 May; 16():149. PubMed ID: 27188161
[TBL] [Abstract][Full Text] [Related]
18. "Rather one more chemo than one less…": Oncologists and Oncology Nurses' Reasons for Aggressive Treatment of Young Adults with Advanced Cancer.
Laryionava K; Heußner P; Hiddemann W; Winkler EC
Oncologist; 2018 Feb; 23(2):256-262. PubMed ID: 29133515
[TBL] [Abstract][Full Text] [Related]
19. Mixed-Methods Study of the Impact of Chronic Patient Death on Oncologists' Personal and Professional Lives.
Granek L; Ariad S; Nakash O; Cohen M; Bar-Sela G; Ben-David M
J Oncol Pract; 2017 Jan; 13(1):e1-e10. PubMed ID: 28084882
[TBL] [Abstract][Full Text] [Related]
20. Utilization of genomic testing in advanced non-small cell lung cancer among oncologists in the Veterans Health Administration.
Arney J; Helm A; Crook T; Braun UK; Chen GJ; Hayes TG
Lung Cancer; 2018 Feb; 116():25-29. PubMed ID: 29413047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
